DIA Biosimilars 2013

Chiltern

Chiltern names Andrew Monaghan director, global pharmacovigilance

Friday, July 26, 2013 03:07 PM

Global CRO Chiltern International has appointed Andrew Monaghan, Ph.D., director, global pharmacovigilance. Monaghan will lead the pharmacovigilance team and expand the company’s pharmacovigilance offering.

More... »

Cenduit: Now with Patient Reminders

Chiltern promotes Alecia Barbee to VP, Global Biometrics

Tuesday, June 4, 2013 12:00 PM

Global CRO Chiltern International has promoted Alecia Barbee to VP, Global Biometrics.

More... »

CRF Health – eCOA Forum

Chiltern appoints Niewel and Bull to senior positions

Thursday, May 16, 2013 08:00 AM

Chiltern International, a global CRO based in the U.K., has appointed Dr. Manuela Niewel as medical director and Lisa Bull as director of strategic partnerships.

More... »

Chiltern promotes Stuart McGuire and Jim Szymeczek

Thursday, March 28, 2013 08:00 AM

Chiltern International, a global contract CRO, has promoted Stuart McGuire to the position of vice president of global business development, and Jim Szymeczek to the position of vice president of global information technology and systems.

More... »

Sotio selects Chiltern International for phase III trial

Monday, March 18, 2013 12:13 PM

Sotio, a Czech Republic-based biotechnology company developing a next generation Active Cellular Immunotherapy, has selected Chiltern International to be the CRO that carries out the European part of its phase III global clinical trial titled VIABLE, which will include 1,170 prostate cancer patients from Europe and the U.S.

More... »

The CenterWatch Monthly, March 2013

Friday, March 1, 2013 08:00 AM

Sites rate the best sponsors 2013

More... »

Chiltern wins PharmaTimes award

Monday, February 4, 2013 10:23 AM

Chiltern International, a global CRO, has won an award at the PharmaTimes Annual Awards 2012. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.

More... »

Chiltern welcomes Cedric Burg and James Gunter

Wednesday, December 12, 2012 11:29 AM

Chiltern International, a global CRO, has appointed Dr. Cedric Burg and James Gunter to their team.

More... »

Chiltern promotes Aize Smink and Linda Christmas

Thursday, November 29, 2012 08:00 AM

Chiltern International, a global CRO, has promoted Aize Smink and Linda Christmas to executive positions, coinciding with Dr. Jim Esinhart’s appointment as CEO.

More... »

Chiltern forms new legal entity In Taiwan

Thursday, April 26, 2012 03:03 PM

CRO Chiltern International has established a new legal entity in Taiwan.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs